-
1
-
-
79959485796
-
Autologous stem cell transplantation as first-line treatment strategy for chronic lymphocytic leukemia: A multicenter, randomized, controlled trial from the SFGM-TC and GFLLC
-
Sutton L, Chevret S, Tournilhac O, et al. Autologous stem cell transplantation as first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC. Blood. 2011;117(23):6109-6119.
-
(2011)
Blood
, vol.117
, Issue.23
, pp. 6109-6119
-
-
Sutton, L.1
Chevret, S.2
Tournilhac, O.3
-
2
-
-
0027225899
-
Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia
-
Rabinowe SN, Soiffer RJ, Gribben JG, et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood. 1993;82(23):1366-1377.
-
(1993)
Blood
, vol.82
, Issue.23
, pp. 1366-1377
-
-
Rabinowe, S.N.1
Soiffer, R.J.2
Gribben, J.G.3
-
3
-
-
79551631475
-
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: Results of the European intergroup randomized trial comparing autografting versus observation
-
Michallet M, Dreger P, Sutton L, et al. Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of the European intergroup randomized trial comparing autografting versus observation. Blood. 2011;117(5):1561-1521.
-
(2011)
Blood
, vol.117
, Issue.5
, pp. 1561-1521
-
-
Michallet, M.1
Dreger, P.2
Sutton, L.3
-
4
-
-
20644447584
-
Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia
-
Moreno C, Villamor N, Colomer D, et al. Allogeneic stem-cell transplantation may overcome the adverse prognosis of unmutated VH gene in patients with chronic lymphocytic leukemia. J Clin Oncol. 2005;23(15):3433-3438.
-
(2005)
J Clin Oncol.
, vol.23
, Issue.15
, pp. 3433-3438
-
-
Moreno, C.1
Villamor, N.2
Colomer, D.3
-
5
-
-
32644435470
-
How I treat refractory CLL
-
DOI 10.1182/blood-2005-02-0819
-
Montserrat E, Moreno C, Esteve J, Urbano-Ispizua A, Gine E, Bosch F. How I treat refractory CLL. Blood. 2006;107(4):1276-1283. (Pubitemid 43242359)
-
(2006)
Blood
, vol.107
, Issue.4
, pp. 1276-1283
-
-
Montserrat, E.1
Moreno, C.2
Esteve, J.3
Urbano-Ispizua, A.4
Gine, E.5
Bosch, F.6
-
6
-
-
33845543049
-
Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: The EBMT transplant consensus
-
DOI 10.1038/sj.leu.2404441, PII 2404441
-
Dreger P, Corradini P, Kimby E, et al. Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus. Leukemia. 2007;21(1):12-17. (Pubitemid 44921829)
-
(2007)
Leukemia
, vol.21
, Issue.1
, pp. 12-17
-
-
Dreger, P.1
Corradini, P.2
Kimby, E.3
Michallet, M.4
Milligan, D.5
Schetelig, J.6
Wiktor-Jedrzejczak, W.7
Niederwieser, D.8
Hallek, M.9
Montserrat, E.10
-
7
-
-
70350475037
-
Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: Ready for prime time?
-
Delgado J, Milligan DW, Dreger P. Allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia: ready for prime time? Blood. 2009;114(13):2581-2588.
-
(2009)
Blood
, vol.114
, Issue.13
, pp. 2581-2588
-
-
Delgado, J.1
Milligan, D.W.2
Dreger, P.3
-
8
-
-
51649093353
-
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
-
Tam CS, O'Brien S, Wierda W, et al. Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia. Blood. 2008;112(4):975-980.
-
(2008)
Blood
, vol.112
, Issue.4
, pp. 975-980
-
-
Tam, C.S.1
O'brien, S.2
Wierda, W.3
-
9
-
-
77957664665
-
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: A randomised, open-label, phase 3 trial
-
Hallek M, Fischer K, Fingerle-Rowson G, et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet. 2010;376(9747):1164-1174.
-
(2010)
Lancet
, vol.376
, Issue.9747
, pp. 1164-1174
-
-
Hallek, M.1
Fischer, K.2
Fingerle-Rowson, G.3
-
10
-
-
28844483804
-
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia
-
DOI 10.1182/blood-2005-05-1778
-
Gribben JG, Zahrieh D, Stephans K, et al. Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia. Blood. 2005;106(13): 4389-4396. (Pubitemid 41775953)
-
(2005)
Blood
, vol.106
, Issue.13
, pp. 4389-4396
-
-
Gribben, J.G.1
Zahrieh, D.2
Stephans, K.3
Bartlett-Pandite, L.4
Alyea, E.P.5
Fisher, D.C.6
Freedman, A.S.7
Mauch, P.8
Schlossman, R.9
Sequist, L.V.10
Soiffer, R.J.11
Marshall, B.12
Neuberg, D.13
Ritz, J.14
Nadler, L.M.15
-
11
-
-
78650651439
-
Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia
-
Gribben JG, Hosing C, Maloney DG. Stem cell transplantation for indolent lymphoma and chronic lymphocytic leukemia. Biol Blood Marrow Transplant. 2011;17(1 suppl): S63-S70.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, Issue.1 SUPPL.
-
-
Gribben, J.G.1
Hosing, C.2
Maloney, D.G.3
|